These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30897572)

  • 21. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
    Yücel M; Bora E; Lubman DI; Solowij N; Brewer WJ; Cotton SM; Conus P; Takagi MJ; Fornito A; Wood SJ; McGorry PD; Pantelis C
    Schizophr Bull; 2012 Mar; 38(2):316-30. PubMed ID: 20660494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis use and neurocognitive functioning in a non-clinical sample of users.
    Thames AD; Arbid N; Sayegh P
    Addict Behav; 2014 May; 39(5):994-9. PubMed ID: 24556155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
    Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF
    Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study.
    van Dijk D; Koeter MW; Hijman R; Kahn RS; van den Brink W
    Schizophr Res; 2012 May; 137(1-3):50-7. PubMed ID: 22313726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study.
    Bourque J; Mendrek A; Durand M; Lakis N; Lipp O; Stip E; Lalonde P; Grignon S; Potvin S
    Psychiatry Res; 2013 Oct; 214(1):24-32. PubMed ID: 23906663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No additive effect of cannabis on cognition in schizophrenia.
    Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC
    Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use related to early psychotic onset: Role of premorbid function.
    Frascarelli M; Quartini A; Tomassini L; Russo P; Zullo D; Manuali G; De Filippis S; Bersani G
    Neurosci Lett; 2016 Oct; 633():55-61. PubMed ID: 27637389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.
    Baudin G; Godin O; Lajnef M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Fond G; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Tronche AM; Misdrahi D; Rey R; Passerieux C; Schandrin A; Urbach M; Vidalhet P; Llorca PM; Schürhoff F;
    Schizophr Res; 2016 Aug; 175(1-3):161-167. PubMed ID: 27209524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long lasting effects of chronic heavy cannabis abuse.
    Nestoros JN; Vakonaki E; Tzatzarakis MN; Alegakis A; Skondras MD; Tsatsakis AM
    Am J Addict; 2017 Jun; 26(4):335-342. PubMed ID: 28314070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition.
    Ventura J; Cienfuegos A; Boxer O; Bilder R
    Schizophr Res; 2008 Nov; 106(1):59-69. PubMed ID: 17900866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Arnold C; Allott K; Farhall J; Killackey E; Cotton S
    Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression.
    Tourjman SV; Juster RP; Purdon S; Stip E; Kouassi E; Potvin S
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):49-56. PubMed ID: 29553848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.